The development of effective treatments for Crohn's disease has been hampered by the lack of animal models that faithfully reproduce one of its most distinctive features: creeping fat, the abnormal growth of fatty tissue around inflamed intestines. This pathological fat accumulation may drive disease progression, yet researchers have struggled to study it mechanistically without appropriate experimental systems.
Using TNBS-induced colitis in rats, investigators successfully generated mesocolic adipose hyperplasia that closely mirrors human creeping fat morphology and molecular signatures. The model demonstrated that only animals with severe colonoscopic inflammation scores (above 7 out of 9) developed significant fat hyperplasia, establishing a clear correlation between intestinal inflammation severity and adipose tissue pathology. Molecular analysis revealed upregulation of key inflammatory cytokines including IL-1β, IL-6, and TNF-α, alongside increased expression of pathogen-recognition receptors TLR2, matching patterns observed in human Crohn's disease.
This represents a significant methodological advance for inflammatory bowel disease research. Previous animal models largely failed to recapitulate the creeping fat phenotype, limiting investigation into how this adipose tissue dysfunction contributes to disease chronicity and treatment resistance. The strong correlation between inflammation severity and fat hyperplasia suggests these processes are mechanistically linked rather than coincidental. For therapeutic development, this model provides a crucial platform for testing interventions targeting the fat-inflammation axis in Crohn's disease, potentially opening new treatment avenues beyond current immunosuppressive approaches that often prove inadequate for long-term disease control.